Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Christine A Olson
Affiliation
University of California los angeles
ORCID
Career Start Year
1988
Papers
51
H Index
32
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
38070135
Ketogenic diet therapy for pediatric epilepsy is associated with alterations in the human gut microbiome that confer seizure resistance in mice.
Cell Rep
2023
35114110
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display.
Cell Rep
2022
36047699
STENSL: Microbial Source Tracking with ENvironment SeLection.
mSystems
2022
34358434
Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia.
Cell Host Microbe
2021
33790226
Gut microbial taxa elevated by dietary sugar disrupt memory function.
Transl Psychiatry
2021
31445165
Emerging roles for the intestinal microbiome in epilepsy.
Neurobiol Dis
2020
32415096
mRNA display with library of even-distribution reveals cellular interactors of influenza virus NS1.
Nat Commun
2020
32275853
Toward Understanding Microbiome-Neuronal Signaling.
Mol Cell
2020
32492391
Ketone Bodies Exert Ester-Ordinary Suppression of Bifidobacteria and Th17 Cells.
Cell Metab
2020
30007420
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet.
Cell
2018
29804833
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet.
Cell
2018
28441397
Correction: Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality.
PLoS Genet
2017
28159892
Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
Proc Natl Acad Sci U S A
2017
28092661
Interactions between the microbiota, immune and nervous systems in health and disease.
Nat Neurosci
2017
27573121
The Microbial Olympics 2016.
Nat Microbiol
2016
26540565
High-throughput identification of protein mutant stability computed from a double mutant fitness landscape.
Protein Sci
2016
27391790
Adaptation in protein fitness landscapes is facilitated by indirect paths.
Elife
2016
26132554
Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality.
PLoS Genet
2015
24169581
Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration.
J Antimicrob Chemother
2014
25455030
A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain.
Curr Biol
2014
25522661
High-throughput profiling of point mutations across the HIV-1 genome.
Retrovirology
2014
25271282
A comprehensive functional map of the hepatitis C virus genome provides a resource for probing viral proteins.
mBio
2014
24965464
High-throughput identification of loss-of-function mutations for anti-interferon activity in the influenza A virus NS segment.
J Virol
2014
24842159
HIV-1 quasispecies delineation by tag linkage deep sequencing.
PLoS One
2014
24820965
High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution.
Sci Rep
2014
24722365
A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity.
PLoS Pathog
2014
23791193
Recombinant probes for visualizing endogenous synaptic proteins in living neurons.
Neuron
2013
23125174
Single-round, multiplexed antibody mimetic design through mRNA display.
Angew Chem Int Ed Engl
2012
21761516
Rapid mRNA-display selection of an IL-6 inhibitor using continuous-flow magnetic separation.
Angew Chem Int Ed Engl
2011
21028792
Importance of controlling nanotube density for highly sensitive and reliable biosensors functional in physiological conditions.
ACS Nano
2010
19422193
Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes.
ACS Nano
2009
19364769
mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.
J Biol Chem
2009
18590330
mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin.
ACS Chem Biol
2008
17322532
Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.
Protein Sci
2007
11931761
Structure of the bacterial RNA polymerase promoter specificity sigma subunit.
Mol Cell
2002
12488007
Non-classical helix-stabilizing interactions: C-H...O H-bonding between Phe and Glu side chains in alpha-helical peptides.
Biophys Chem
2002
12440888
D/H amide isotope effect in model alpha-helical peptides.
J Am Chem Soc
2002
12091708
Polyproline II structure in a sequence of seven alanine residues.
Proc Natl Acad Sci U S A
2002
11955433
Crystal structure of the Bacillus stearothermophilus anti-sigma factor SpoIIAB with the sporulation sigma factor sigmaF.
Cell
2002
11916412
Cation-pi interaction in model alpha-helical peptides.
J Am Chem Soc
2002
11427086
Polar interactions with aromatic side chains in alpha-helical peptides: Ch...O H-bonding and cation-pi interactions.
J Am Chem Soc
2001
12115147
Stabilization of alpha-helix structure by polar side-chain interactions: complex salt bridges, cation-pi interactions, and C-H em leader O H-bonds.
Biopolymers
2001
11391775
Cooperative helix stabilization by complex Arg-Glu salt bridges.
Proteins
2001
7511927
Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant.
Int Immunol
1994
7517977
Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
J Immunol
1994
1730925
Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
J Exp Med
1992
1829720
Dissection of binding vs. recognition functions of H-2 class-I synthetic peptides which are recognized by alloreactive cytotoxic T lymphocytes.
Int J Cancer Suppl
1991
1834760
The thymus leukemia antigen binds human and mouse CD8.
J Exp Med
1991
1700053
Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
J Exp Med
1990
2783781
Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.
Proc Natl Acad Sci U S A
1989
1 - 50 of 51
Column Actions
Search
Recommended Authors
Arthur O Zalevsky
University of California san francisco
Career Start Year
2015
Number of shared co-authors
0
Connie Chen
University of California davis
Career Start Year
2009
Number of shared co-authors
0
Fergal Casey
Biogen Inc.
Career Start Year
2006
Number of shared co-authors
1
Abhishek K Jha
Elucidata Corporation
Career Start Year
2005
Number of shared co-authors
1
David Marciano
Stanford Cardiovascular Institute (L.W., Stanford University School of Medicine
Career Start Year
2003
Number of shared co-authors
0
Andrey Tovchigrechko
J. Craig Venter Institute, 9605 Medical Center Dr
Career Start Year
2001
Number of shared co-authors
0
Lewyn Li
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2000
Number of shared co-authors
0
Jason F Kreisberg
University of California San Diego
Career Start Year
2000
Number of shared co-authors
2
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year
1998
Number of shared co-authors
1
Daron M Standley
Osaka university
Career Start Year
1998
Number of shared co-authors
1
Hamid R Kalhor
Sharif University of Technology
Career Start Year
1998
Number of shared co-authors
0
Erik Verschueren
University of California San Francisco
Career Start Year
1997
Number of shared co-authors
3
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Career Start Year
1997
Number of shared co-authors
0
Pavel Strop
Pfizer Inc.
Career Start Year
1997
Number of shared co-authors
0
Alexei A Podtelezhnikov
Genetics and Pharmacogenomics, Merck & Co., Inc.
Career Start Year
1994
Number of shared co-authors
0
Jaume Pons
Pfizer Inc.
Career Start Year
1994
Number of shared co-authors
0
Aw Edith Chan
The Walter and Eliza Hall Institute of Medical Research
Career Start Year
1993
Number of shared co-authors
0
Anthony W Purcell
Monash Biomedicine Discovery Institute, Monash University
Career Start Year
1989
Number of shared co-authors
0
Roman Jerala
National Institute of Chemistry
Career Start Year
1988
Number of shared co-authors
0
Miriam Eisenstein
Weizmann Institute of Science
Career Start Year
1988
Number of shared co-authors
0
Steven C Almo
Albert Einstein College of Medicine
Career Start Year
1988
Number of shared co-authors
1
Denis C Shields
Conway Institute of Biomolecular and Biomedical Research, University College Dublin
Career Start Year
1987
Number of shared co-authors
2
Jorge Eduardo Fajardo
Albert Einstein College of Medicine
Career Start Year
1982
Number of shared co-authors
0
Ruth Nussinov
Sackler School of Medicine, Tel Aviv University
Career Start Year
1980
Number of shared co-authors
0
David S Moss
Institute of Structural and Molecular Biology, University of London
Career Start Year
1976
Number of shared co-authors
0
Gianni Cesareni
University of Rome 'Tor Vergata'
Career Start Year
1976
Number of shared co-authors
0
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year
1975
Number of shared co-authors
3
James A Wells
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year
1974
Number of shared co-authors
0
Andras Fiser
Albert Einstein College of Medicine
Career Start Year
1968
Number of shared co-authors
1
David Eisenberg
university of california los angeles
Career Start Year
1963
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Ren Sun
University of California los angeles
Co-authored papers
20
Ting-Ting Wu
Xinjiang Medical University Affiliated First Hospital
Co-authored papers
10
Yushen Du
University of California los angeles
Co-authored papers
6
Zugen Chen
David Geffen School of Medicine, University of California los angeles
Co-authored papers
3
Danyang Gong
David Geffen School of Medicine, University of California los angeles
Co-authored papers
3
Xinmin Li
University of California los angeles
Co-authored papers
3
Jun Feng
University of California los angeles
Co-authored papers
2
Lei Dai
Xiangya Hospital of Central South University
Co-authored papers
2
Seth A Darst
The Rockefeller University
Co-authored papers
2
Kejun Tang
Women's Hospital, Zhejiang University
Co-authored papers
1
Hongyu Deng
Cancer Research Institute, Central South University
Co-authored papers
1
Daniel B Kearns
Indiana University
Co-authored papers
1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
1
Otto O Yang
Co-authored papers
1
Eric J Alm
Massachusetts Institute of Technology 21 Ames St. Cambridge
Co-authored papers
1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Co-authored papers
1
Christopher S Smillie
Co-authored papers
1
Tian-Hao Zhang
David Geffen School of Medicine, University of California los angeles
Co-authored papers
1
Liubo Chen
The Second Affiliated Hospital of Zhejiang University
Co-authored papers
1
Pamela J Bjorkman
Co-authored papers
1
Xinming Li
David Geffen School of Medicine at university of california los angeles
Co-authored papers
1
Steve Bensenger
University of California los angeles
Co-authored papers
1
Stanley F Nelson
university of california los angeles
Co-authored papers
1
Yen-Wen Tseng
University of California los angeles
Co-authored papers
1
Ron Stewart
Co-authored papers
1
Tobin R Sosnick
Institute for Biophysical Dynamics, The University of Chicago
Co-authored papers
1
Ralph S Baric
University of North Carolina
Co-authored papers
1
Jonathan Diep
Amgen Inc.
Co-authored papers
1
Michael J McGregor
J. David Gladstone Institutes
Co-authored papers
1
Eran Halperin
Co-authored papers
1
1 - 30